Cardiovascular and oncologic outcomes of nivolumab + ipilimumab vs. pembrolizumab in malignant melanoma: A global real-world data analysis.

Authors: Shivani Dalal, Abdul Wali Khan, Muhammad Ishaq, Syeda Maryana Mufarrih, Tanzeel Rehman, Abat Khan, Matthew Philip Salzberg, Atif Hussein

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e21538

Source: Full article

---

Abstract

e21538